#biotech

📰News 🌐 Macro — 📊 Neutral

Webinar Explores Strategies for Scaling Advanced Therapy Supply Chains

November 3, 2026 (7 days ago)

Learn how to optimize global advanced therapy distribution through strategic supply chain management and regulatory navigation across key international markets.

🌍 GLOBAL Read More →

🏢Release 📈 Stocks — 📊 Neutral

Pyramid Pharma Services Launches New Cartridge Program for Blood Cancer Drugs

November 3, 2026 (7 days ago)

Pyramid Pharma Services expands its CDMO capabilities with a new cartridge-based manufacturing platform designed to accelerate the delivery of life-saving rare blood…

🌍 US Read More →

🏢Release 📈 Stocks

Differentia Bio Advances AI-Driven Disease Modeling for Pharma R&D

November 3, 2026 (7 days ago)

Differentia Bio expands its AI-driven disease modeling capabilities, aiming to streamline pharmaceutical R&D through high-fidelity digital twins and molecular data analysis.

DIFFERENTIA_BIO

🌍 AMERICAS Read More →

📰News 📈 Stocks

Bright Minds Biosciences Shares Slide on FDA Partial Clinical Hold

November 3, 2026 (7 days ago)

Bright Minds Biosciences stock faces downward pressure as the FDA halts its Phase 2 epilepsy trial due to toxicity concerns, prompting legal…

DRUG

🌍 AMERICAS Read More →

📊Earnings 📈 Stocks

BioMarin Q3 Revenue Climbs 32% to $1.025 Billion Amid Guidance Revision

November 2, 2026 (7 days ago)

BioMarin posts $1.025 billion in Q3 revenue, a 32% jump, but tempers full-year expectations due to order timing volatility and R&D investment…

BMRN

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

GOA Therapeutics Appoints 40-Year Industry Veteran as Chief Medical Officer

November 2, 2026 (8 days ago)

GOA Therapeutics bolsters its clinical development pipeline by hiring a veteran executive with extensive experience in drug launches and medical affairs to…

GOA Therapeutics GILD

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Endeavor Health and GoPath Diagnostics Launch Novel Prostate Cancer Test

November 2, 2026 (8 days ago)

Endeavor Health and GoPath Diagnostics introduce a new genetic screening tool for aggressive prostate cancer, aiming to improve clinical outcomes through early…

Endeavor Health GoPath Diagnostics

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Supernus Completes Indivior Merger to Form CNS Biopharma Leader

November 2, 2026 (8 days ago)

Supernus Pharmaceuticals completes its strategic merger with Indivior, creating a new, diversified biopharmaceutical leader dedicated to advancing treatments for central nervous system…

SUPN INDV

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

IntelliGenome Partners with NL Diagnóstica to Expand TB Testing in Brazil

November 2, 2026 (8 days ago)

IntelliGenome and NL Diagnóstica join forces to bring CRISPR-based tuberculosis diagnostic tools to the Brazilian market, marking a strategic expansion for both…

IntelliGenome NL Diagnóstica

🌍 LATAM Read More →

🏢Release 📈 Stocks

Bold Therapeutics Presents BOLD-100 Clinical Updates at BIO-Europe

November 2, 2026 (8 days ago)

Bold Therapeutics updates stakeholders on the clinical advancement of BOLD-100 during the BIO-Europe conference, focusing on its proprietary metallotherapeutics pipeline.

BOLD THERAPEUTICS

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

CRISPR Therapeutics Appoints Siva Sakhamuri as Chief Technical Officer

November 2, 2026 (8 days ago)

CRISPR Therapeutics strengthens its technical leadership team with the appointment of industry veteran Dr. Siva Sakhamuri to oversee manufacturing and technical operations.

CRSP

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

OncoC4 Appoints Dr. Dan Janiak as Chief Business Officer to Lead Strategy

November 2, 2026 (8 days ago)

Clinical-stage biopharma firm OncoC4 appoints industry veteran Dr. Dan Janiak as Chief Business Officer to bolster its executive leadership and strategic business…

OncoC4

🌍 US Read More →